🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
70 results for “Amgen”
MedicineActive substanceLicence holderStatus
Otezla 10 mg film-coated tablets Otezla 20 mg film-coated tablets Otezla 30 mg film-coated tablets
EU/1/14/981/001
Apremilast, Apremilast, Apremilast Amgen Europe B.V.,
Otezla 20 mg film–coated tablets
EU/1/14/981/005
Apremilast Amgen Europe B.V.,
Otezla 30 mg film-coated tablets
EU/1/14/981/002-003
Apremilast Amgen Europe B.V.,
Parsabiv 10 mg solution for injection
EU/1/16/1142/009-012
Etelcalcetide hydrochloride Amgen Europe B.V.,
Parsabiv 2.5 mg solution for injection
EU/1/16/1142/001-004
Etelcalcetide hydrochloride Amgen Europe B.V.,
Parsabiv 5 mg solution for injection
EU/1/16/1142/005-008
Etelcalcetide hydrochloride Amgen Europe B.V.,
PAVBLU 40 mg/mL solution for injection in a vial
EU/1/25/1909/002
Aflibercept Amgen Technology (Ireland) Unlimited Company
PAVBLU 40 mg/mL solution for injection in pre-filled syringe
EU/1/25/1909/001
Aflibercept Amgen Technology (Ireland) Unlimited Company
Prolia 60 mg solution for injection in pre-filled syringe
EU/1/10/618/1-4
Denosumab Amgen Europe B.V.,
Repatha 140 mg solution for injection in pre-filled pen
EU/1/15/1016/002-005
Evolocumab Amgen Europe B.V.
Repatha 140 mg solution for injection in pre-filled syringe
EU/1/15/1016/001
Evolocumab Amgen Europe B.V.,
Repatha 420 mg solution for injection in cartridge
EU/1/15/1016/006-007
Evolocumab Amgen Europe B.V.
TEPEZZA 500 mg powder for concentrate for solution for infusion
EU/1/25/1941/001
Teprotumumab Amgen Europe B.V.,
Uplizna 100 mg concentrate for solution for infusion
EU/1/21/1602/001
Inebilizumab Amgen Europe B.V.,
Vectibix 20 mg/mL concentrate for solution for infusion
EU/1/07/423/001-003
Panitumumab Amgen Europe B.V.,
WEZENLA 130 mg Concentrate for solution for infusion
EU/1/24/1823/004
Ustekinumab Amgen Technology (Ireland) UC
WEZENLA 45 mg Solution for injection
EU/1/24/1823/001
Ustekinumab Amgen Technology (Ireland) UC
WEZENLA 45 mg Solution for injection pre-filled syringe
EU/1/24/1823/002
Ustekinumab Amgen Technology (Ireland) UC
WEZENLA 90 mg Solution for injection pre-filled syringe
EU/1/24/1823/003
Ustekinumab Amgen Technology (Ireland) UC
XGEVA 120 mg solution for injection
EU/1/11/703/001-002
Denosumab Amgen Europe B.V.,
1 2
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.